Company research
THERMO FISHER SCIENTIFIC INC.
CIK 97745Updated Sep 26, 2026
SecurityTMO · NYSE · equity
Name history
THERMO ELECTRON CORP · through Nov 3, 2006
TMO price & chart
Loading TradingView…
NYSE:TMO on TradingView ↗About the company
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $45 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Gibco, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.
In the news
Seeking Alpha
Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q2 2026 Update ↗
Notable healthcare headlines for the week: Novo Nordisk, GE HealthCare, and Eli Lilly in focus ↗
Thermo Fisher Scientific Inc. (TMO) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript ↗
Recent filings
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 110,343,000,000Source | 97,321,000,000Source | 98,726,000,000Source | 97,154,000,000Source |
| Property, Plant and Equipment, NetUSD | 10,565,000,000Source | 9,306,000,000Source | 9,448,000,000Source | 9,280,000,000Source |
| GoodwillUSD | 49,362,000,000Source | 45,853,000,000Source | 44,020,000,000Source | 41,196,000,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 15,838,000,000Source | 15,533,000,000Source | 16,670,000,000Source | 17,442,000,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 9,852,000,000Source | 4,009,000,000Source | 8,077,000,000Source | 8,524,000,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 8,900,000,000Source | 8,191,000,000Source | 8,221,000,000Source | 8,115,000,000Source |
| Inventory, NetUSD | 5,425,000,000Source | 4,978,000,000Source | 5,088,000,000Source | 5,634,000,000Source |
| Assets, CurrentUSD | 28,707,000,000Source | 22,137,000,000Source | 24,589,000,000Source | 25,229,000,000Source |
| Operating Lease, Right-of-Use AssetUSD | 1,447,000,000Source | 1,489,000,000Source | 1,556,000,000Source | 1,593,000,000Source |
| Other Assets, NoncurrentUSD | 5,871,000,000Source | 4,492,000,000Source | 3,999,000,000Source | 4,007,000,000Source |
| LIABILITIES AND EQUITY | ||||
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 0Source | — | — | — |
| Common Stock, Value, IssuedUSD | 445,000,000Source | 444,000,000Source | 442,000,000Source | 441,000,000Source |
| Retained Earnings (Accumulated Deficit)USD | 59,156,000,000Source | 53,102,000,000Source | 47,364,000,000Source | 41,910,000,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -2,448,000,000Source | -2,697,000,000Source | -3,224,000,000Source | -3,099,000,000Source |
| Stockholders' Equity Attributable to ParentUSD | 53,407,000,000Source | 49,584,000,000Source | 46,735,000,000Source | 43,978,000,000Source |
| Additional Paid in Capital, Common StockUSD | 18,563,000,000Source | 17,962,000,000Source | 17,286,000,000Source | 16,743,000,000Source |
| Liabilities and EquityUSD | 110,343,000,000Source | 97,321,000,000Source | 98,726,000,000Source | 97,154,000,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 15,189,000,000Source | 13,332,000,000Source | 14,012,000,000Source | 17,010,000,000Source |
| Operating Lease, Liability, CurrentUSD | 275,000,000Source | 261,000,000Source | 263,000,000Source | 272,000,000Source |
| Accounts Payable, CurrentUSD | 3,622,000,000Source | 3,079,000,000Source | 2,872,000,000Source | 3,381,000,000Source |
| Operating Lease, Liability, NoncurrentUSD | 1,195,000,000Source | 1,239,000,000Source | 1,244,000,000Source | 1,313,000,000Source |
| Deferred Income Tax Liabilities, NetUSD | 1,493,000,000Source | 1,268,000,000Source | 1,922,000,000Source | 2,849,000,000Source |
| Other Liabilities, NoncurrentUSD | 4,273,000,000Source | 3,989,000,000Source | 4,642,000,000Source | 4,238,000,000Source |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | 7,000,000Source | -33,000,000Source | -11,000,000Source | 54,000,000Source |
| Additional Financial Items | ||||
| Deferred Tax Liabilities, NetUSD | — | 338,000,000Source | 1,091,000,000Source | 1,984,000,000Source |
| Dividends PayableUSD | 164,000,000Source | 150,000,000Source | 137,000,000Source | 119,000,000Source |
| Long-term DebtUSD | 39,172,000,000Source | 31,072,000,000Source | 34,727,000,000Source | 34,278,000,000Source |
| Redeemable Noncontrolling Interest, Equity, Carrying AmountUSD | 122,000,000Source | 120,000,000Source | 118,000,000Source | 116,000,000Source |
| Short-term InvestmentsUSD | 253,000,000Source | 1,561,000,000Source | — | — |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | 6,721,000,000Source | 6,338,000,000Source | 5,955,000,000Source | 6,960,000,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | 310,000,000Source | 301,000,000Source | 278,000,000Source | 307,000,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | 426,000,000Source | 171,000,000Source | 43,000,000Source | 430,000,000Source |
| Increase (Decrease) in InventoriesUSD | 74,000,000Source | 27,000,000Source | -598,000,000Source | 825,000,000Source |
| Increase (Decrease) in Accounts PayableUSD | 421,000,000Source | 212,000,000Source | -500,000,000Source | 648,000,000Source |
| Deferred Income Tax Expense (Benefit)USD | -639,000,000Source | -1,209,000,000Source | -1,300,000,000Source | -997,000,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | 7,818,000,000Source | 8,667,000,000Source | 8,406,000,000Source | 9,154,000,000Source |
| Cash flows from investing activities: | ||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | 4,037,000,000Source | 3,132,000,000Source | 3,660,000,000Source | 39,000,000Source |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -4,047,000,000Source | -5,841,000,000Source | -5,142,000,000Source | -2,159,000,000Source |
| Payments for (Proceeds from) Other Investing ActivitiesUSD | -21,000,000Source | -8,000,000Source | 160,000,000Source | -99,000,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 1,525,000,000Source | 1,400,000,000Source | 1,479,000,000Source | 2,243,000,000Source |
| Cash flows from financing activities: | ||||
| Payments for Repurchase of Common StockUSD | 3,000,000,000Source | 4,000,000,000Source | 3,000,000,000Source | 3,000,000,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 1,801,000,000Source | -6,792,000,000Source | -3,622,000,000Source | -2,810,000,000Source |
| Payments of Ordinary Dividends, Common StockUSD | 636,000,000Source | 583,000,000Source | 523,000,000Source | 455,000,000Source |
| Proceeds from (Payments for) Other Financing ActivitiesUSD | 90,000,000Source | 195,000,000Source | 56,000,000Source | -9,000,000Source |
| Repayments of Long-term DebtUSD | 2,412,000,000Source | 3,607,000,000Source | 5,782,000,000Source | 375,000,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 5,839,000,000Source | -4,057,000,000Source | -440,000,000Source | 4,046,000,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 9,879,000,000Source | 4,040,000,000Source | 8,097,000,000Source | 8,537,000,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 1,612,000,000Source | 1,570,000,000Source | 1,385,000,000Source | 667,000,000Source |
| Income Taxes Paid, NetUSD | 1,776,000,000Source | — | — | — |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 1,730,000,000Source | 1,952,000,000Source | 2,338,000,000Source | 2,395,000,000Source |
| DepreciationUSD | 1,050,000,000Source | 1,156,000,000Source | 1,068,000,000Source | 986,000,000Source |
| Dividends PayableUSD | 164,000,000Source | 150,000,000Source | 137,000,000Source | 119,000,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | -130,000,000Source | 0Source | -67,000,000Source | 62,000,000Source |
| Gain (Loss) on InvestmentsUSD | 13,000,000Source | 21,000,000Source | -46,000,000Source | -161,000,000Source |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | 0Source | -26,000,000Source |
| GoodwillUSD | 49,362,000,000Source | 45,853,000,000Source | 44,020,000,000Source | 41,196,000,000Source |
| Income (Loss) from Equity Method InvestmentsUSD | -41,000,000Source | -42,000,000Source | -59,000,000Source | -172,000,000Source |
| Income Tax Expense (Benefit)USD | 547,000,000Source | 657,000,000Source | 284,000,000Source | 703,000,000Source |
| InterestExpenseNonoperatingUSD | 1,419,000,000Source | 1,390,000,000Source | — | — |
| Investment Income, InterestUSD | 993,000,000Source | 1,078,000,000Source | 879,000,000Source | 272,000,000Source |
| Net Income (Loss) Attributable to ParentUSD | 6,704,000,000Source | — | — | — |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | 17,000,000Source | 3,000,000Source | -40,000,000Source | 10,000,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | 6,335,000,000Source | 5,995,000,000Source | 6,950,000,000Source |
| Other Nonoperating Income (Expense)USD | -12,000,000Source | 12,000,000Source | -65,000,000Source | -104,000,000Source |
| Payments to Acquire InvestmentsUSD | 383,000,000Source | 3,396,000,000Source | — | — |
| Proceeds from Issuance of Long-term DebtUSD | 7,759,000,000Source | 1,204,000,000Source | 5,942,000,000Source | 3,193,000,000Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 44,556,000,000Source | 42,879,000,000Source | 42,857,000,000Source | 44,915,000,000Source |
| Selling, General and Administrative ExpenseUSD | 8,732,000,000Source | 8,595,000,000Source | 8,445,000,000Source | 8,993,000,000Source |
| Operating Income (Loss)USD | 7,746,000,000Source | 7,337,000,000Source | 6,859,000,000Source | 8,393,000,000Source |
| Other Nonoperating Income (Expense)USD | -12,000,000Source | 12,000,000Source | -65,000,000Source | -104,000,000Source |
| Income Tax Expense (Benefit)USD | 547,000,000Source | 657,000,000Source | 284,000,000Source | 703,000,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | 17,000,000Source | 3,000,000Source | -40,000,000Source | 10,000,000Source |
| Net Income (Loss) Attributable to ParentUSD | 6,704,000,000Source | — | — | — |
| Earnings Per Share, BasicUSD per share | 17.77Source | 16.58Source | 15.52Source | 17.75Source |
| Earnings Per Share, DilutedUSD per share | 17.74Source | 16.53Source | 15.45Source | 17.63Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 377,000,000Source | 382,000,000Source | 386,000,000Source | 392,000,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 378,000,000Source | 383,000,000Source | 388,000,000Source | 394,000,000Source |
| Interest Expense (non-operating)USD | 1,419,000,000Source | 1,390,000,000Source | — | — |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 1,730,000,000Source | 1,952,000,000Source | 2,338,000,000Source | 2,395,000,000Source |
| Common Stock, Dividends, Per Share, DeclaredUSD per share | 1.72Source | 1.56Source | 1.4Source | 1.2Source |
| Costs and ExpensesUSD | 36,810,000,000Source | 35,542,000,000Source | 35,998,000,000Source | 36,522,000,000Source |
| Current Income Tax Expense (Benefit)USD | 1,186,000,000Source | 1,866,000,000Source | 1,584,000,000Source | 1,700,000,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | -130,000,000Source | 0Source | -67,000,000Source | 62,000,000Source |
| Gain (Loss) on InvestmentsUSD | 13,000,000Source | 21,000,000Source | -46,000,000Source | -161,000,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | 2,608,000,000Source | 2,226,000,000Source | 2,431,000,000Source | 3,859,000,000Source |
| Income (Loss) from Equity Method InvestmentsUSD | -41,000,000Source | -42,000,000Source | -59,000,000Source | -172,000,000Source |
| Interest ExpenseUSD | — | — | 1,375,000,000Source | 726,000,000Source |
| Investment Income, InterestUSD | 993,000,000Source | 1,078,000,000Source | 879,000,000Source | 272,000,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | 6,335,000,000Source | 5,995,000,000Source | 6,950,000,000Source |
| Research and Development ExpenseUSD | 1,397,000,000Source | 1,390,000,000Source | 1,337,000,000Source | 1,471,000,000Source |
Filing attachments
q22026earnings8kex99_1.htm · 8-K · 2026-07-23
EX-99.1 2 q22026earnings8kex99_1.htm EX-99.1 Document Exhibit 99.1 News Media Contact Information: Investor Contact Information: Sandy Pound Rafael Tejada Thermo Fisher Scientific Thermo Fisher Scientific Phone: 781-622-1223 Phone: 781-622-1356 E-mail: sandy.pound@thermofisher.com E-mail: rafael.tejada@thermofisher.com Thermo Fisher Scientific Reports Second Quarter 2026 Results Revenue Gr…
Read attachment ↗q12026earnings8kex99_1.htm · 8-K · 2026-04-23
EX-99.1 2 q12026earnings8kex99_1.htm EX-99.1 Document Exhibit 99.1 News Media Contact Information: Investor Contact Information: Sandy Pound Rafael Tejada Thermo Fisher Scientific Thermo Fisher Scientific Phone: 781-622-1223 Phone: 781-622-1356 E-mail: sandy.pound@thermofisher.com E-mail: rafael.tejada@thermofisher.com Thermo Fisher Scientific Reports First Quarter 2026 Results WALTHAM, Ma…
Read attachment ↗ef20065513_ex4-2.htm · 8-K · 2026-02-12
EX-4.2 3 ef20065513_ex4-2.htm EXHIBIT 4.2 Exhibit 4.2 THERMO FISHER SCIENTIFIC INC., as Issuer AND THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee THIRTIETH SUPPLEMENTAL INDENTURE Dated as of February 12, 2026 4.215% Senior Notes due 2031 4.550% Senior Notes due 2033 4.902% Senior Notes due 2036 5.546% Senior Notes due 2046 THIS THIRTIETH SUPPLEMENTAL INDENTURE (this “Supplemental Indenture”) is dated as of February 12, 2026 between THERMO FISHER SCIENTIFIC INC., a De…
Read attachment ↗q42025earnings8kex99_1.htm · 8-K · 2026-01-29
EX-99.1 2 q42025earnings8kex99_1.htm EX-99.1 Document Exhibit 99.1 News Media Contact Information: Investor Contact Information: Sandy Pound Rafael Tejada Thermo Fisher Scientific Thermo Fisher Scientific Phone: 781-622-1223 Phone: 781-622-1356 E-mail: sandy.pound@thermofisher.com E-mail: rafael.tejada@thermofisher.com Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2025 Resul…
Read attachment ↗ef20060146_ex4-2.htm · 8-K · 2025-12-01
EX-4.2 3 ef20060146_ex4-2.htm EXHIBIT 4.2 Exhibit 4.2 Execution Version THERMO FISHER SCIENTIFIC (FINANCE I) B.V., as Issuer THERMO FISHER SCIENTIFIC INC., as Guarantor AND THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A. as Trustee FIFTH SUPPLEMENTAL INDENTURE Dated as of December 1, 2025 Floating Rate Senior Notes due 2027 3.628% Senior Notes due 2035 THIS FIFTH SUPPLEMENTAL INDENTURE (this “Supplemental Indenture”) is dated as of December 1, 2025 among THERMO FISHER SCIENTIFIC…
Read attachment ↗q32025earnings8kex99_1.htm · 8-K · 2025-10-22
EX-99.1 2 q32025earnings8kex99_1.htm EX-99.1 Document Exhibit 99.1 News Media Contact Information: Investor Contact Information: Sandy Pound Rafael Tejada Thermo Fisher Scientific Thermo Fisher Scientific Phone: 781-622-1223 Phone: 781-622-1356 E-mail: sandy.pound@thermofisher.com E-mail: rafael.tejada@thermofisher.com Thermo Fisher Scientific Reports Third Quarter 2025 Results WALTHAM, Ma…
Read attachment ↗